Tampere, Finland

Sallamaari Ylöniemi

This inventor holds 1 USPTO granted patent. Top assignee: Modulight Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sallamaari Ylöniemi. Retrieved from https://idiyas.com/inventor/sallamaari-ylöniemi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sallamaari Ylöniemi: Innovator in Light-Activated Drug Delivery

Introduction

Sallamaari Ylöniemi is a notable inventor based in Tampere, Finland. He has made significant contributions to the field of drug delivery systems, particularly through his innovative methods that utilize light activation. His work is paving the way for advancements in medical technology and patient care.

Latest Patents

Ylöniemi holds a patent for a "Method for light-activated drug delivery and system." This invention involves a method and system that employs an optical probe coupled to tissue for transmitting light signals. These signals are used to actuate and monitor drug delivery through a multi-phase approach. The first light signal is transmitted to initiate the drug delivery process, while a second light signal, with a different wavelength, is sent simultaneously to enhance monitoring and control.

Career Highlights

Sallamaari Ylöniemi is associated with Modulight Corporation, where he continues to develop and refine his innovative technologies. His work has garnered attention for its potential to revolutionize how medications are delivered within the body, making treatments more effective and targeted.

Collaborations

Ylöniemi collaborates with talented professionals in his field, including Petteri Uusimaa and Robert Perttilä. These partnerships enhance the development of cutting-edge solutions in drug delivery systems.

Conclusion

Sallamaari Ylöniemi's contributions to light-activated drug delivery represent a significant advancement in medical technology. His innovative methods and collaborative efforts are set to improve patient outcomes and transform the landscape of drug administration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…